Index of reports
> Life Threatening Events (10)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dapsone life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Dapsone side effects in 74 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: 74 year old male, weighing 77.6 kg (170.6 pounds)
Reactions: Methaemoglobinaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Dapsone
Possible Dapsone side effects in 65 year old female
Reported by a pharmacist from United States on 2012-06-25
Patient: 65 year old female
Reactions: Malaise, Fatigue, Pancytopenia, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1 tablet twice daily po
Administration route: Oral
Indication: Idiopathic Pulmonary Fibrosis
Dapsone
Dosage: 1 tablet daily po
Administration route: Oral
Indication: Rheumatoid Arthritis
Possible Dapsone side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-22
Patient: female, weighing 76.2 kg (167.6 pounds)
Reactions: Dyspnoea, Chills, Tinea Capitis, Vertigo, Cough, Feeling Cold, Muscle Spasms
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dapsone
Possible Dapsone side effects in 66 year old female
Reported by a individual with unspecified qualification from United States on 2012-04-26
Patient: 66 year old female, weighing 56.7 kg (124.7 pounds)
Reactions: Dysphagia, Enterococcal Infection, Rectal Haemorrhage, Anaemia, Ataxia, Cystitis, Oedema Peripheral, Dizziness, Platelet Count Decreased, Oedema, Gastrooesophageal Reflux Disease, Oesophageal Ulcer
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Temodar
Dosage: 75 mg/m[2]/daily/po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2012-03-12
End date: 2012-04-09
CAP Vorinostat UNK
Dosage: 300 mg/5xw/po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2012-03-12
End date: 2012-04-09
Dapsone
Indication: Product Used FOR Unknown Indication
Decadron
Dosage: po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Dapsone side effects in 57 year old female
Reported by a physician from United States on 2012-03-29
Patient: 57 year old female, weighing 63.5 kg (139.7 pounds)
Reactions: Gastrointestinal Haemorrhage, Anaemia, Pulmonary Embolism, Occult Blood Positive, Small Intestinal Perforation, Hypoxia, Enteritis Infectious, Abscess, Diverticular Perforation, Lymphocyte Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vorinostat
Dosage: 4500 mg; po
Administration route: Oral
Indication: Glioblastoma Multiforme
End date: 2012-02-24
Temozolomide
Dosage: 2160 mg
Indication: Glioblastoma Multiforme
Start date: 2012-02-06
End date: 2012-02-23
Dexamethasone TAB
Dapsone
Possible Dapsone side effects in 57 year old female
Reported by a consumer/non-health professional from United States on 2012-03-28
Patient: 57 year old female, weighing 63.0 kg (138.7 pounds)
Reactions: Gastrointestinal Infection, Gastrointestinal Haemorrhage, Small Intestinal Perforation, Diverticulitis, Abscess, Lymphocyte Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Decadron
Dosage: po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
CAP Vorinostat UNK
Dosage: 300 mg/5xw/po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2012-02-06
End date: 2012-02-24
Temozolomide
Dosage: 75 mg/m [2]/daily/po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2012-02-06
End date: 2012-02-23
Dapsone
Indication: Product Used FOR Unknown Indication
Possible Dapsone side effects in 54 year old male
Reported by a physician from United States on 2012-02-09
Patient: 54 year old male
Reactions: Mental Impairment, Zygomycosis, Pancytopenia, Toxicity To Various Agents, Respiratory Depression, Haemodynamic Instability
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Pyrimethamine TAB
Indication: Toxoplasmosis
Clindamycin
Indication: Toxoplasmosis
Dapsone
Indication: Pneumocystis Jiroveci Pneumonia
Other drugs received by patient: Dexamethasone; Insulin (Insulin)
Possible Dapsone side effects in 20 year old male
Reported by a physician from United States on 2012-02-03
Patient: 20 year old male, weighing 87.0 kg (191.4 pounds)
Reactions: Rash Generalised, Cellulitis, Swelling, Impetigo, Pyrexia, Leukocytosis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Isentress
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2011-07-12
End date: 2011-08-01
Isentress
Administration route: Oral
Indication: HIV Infection
Start date: 2011-07-12
End date: 2011-08-01
Truvada
Indication: HIV Infection
Start date: 2011-01-01
End date: 2011-08-01
Ranitidine
Dapsone
Indication: HIV Infection
Start date: 2011-01-01
End date: 2011-08-01
Other drugs received by patient: Bactrim; Azithromycin
Possible Dapsone side effects in 54 year old male
Reported by a physician from United States on 2012-01-23
Patient: 54 year old male
Reactions: Fundoscopy Abnormal, Zygomycosis, Pancytopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Pyrimethamine TAB
Indication: Toxoplasmosis
Clindamycin
Indication: Toxoplasmosis
Dapsone
Indication: Antifungal Prophylaxis
Dexamethasone TAB
Indication: Brain Oedema
Other drugs received by patient: Insulin
Possible Dapsone side effects in 7 year old female
Reported by a pharmacist from United States on 2012-01-11
Patient: 7 year old female, weighing 24.0 kg (52.8 pounds)
Reactions: Asthma, NO Therapeutic Response, Methaemoglobinaemia, Respiratory Distress
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Dapsone
Other drugs received by patient: Zyrtec; Singulair; Prednisone
|